models, such as 3T3-L1 and 3T3-F442A cell lines, have clarified the mechanisms of adipogenesis (3, 4) . In 3T3-L1 cells, adipocyte differentiation is a process regulated by multiple transcription factors, principally the CCAAT/enhancer binding protein (C/EBP) family and peroxisome proliferator-activated receptor γ (PPARγ). In the presence of hormonal inducers, the expression of C/EBPβ and C/EBPδ temporarily increases (5), followed by the expression of PPARγ and C/EBPα (6, 7) . A cooperative interaction between PPARγ and C/EBPα drives the expression of genes that are necessary for the generation and maintenance of the adipogenic phenotype such as lipid accumulation and insulin sensitivity (8) .
During adipogenesis, adipocytes morphologically change from fibroblastic cells to round and lipid-laden cells. It is well known that actin cytoskeleton regulates the morphology of the cells (9) . Concerning adipogenesis and actin cytoskeleton, it has been reported that adipocyte differentiation results in the conversion of filamentous actin (F-actin) from stress fibers and lamellipodia to cortical actin structures (10) .
During the past several decades, many studies have shed light on the molecular mechanisms of actin cytoskeletal regulation. Members of the Rho family are essential regulatory components of the signaling pathway that directs reorganization of actin cytoskeleton. Small GTPase Rho contributes to many cellular functions such as cell motility, adhesion and cytokinesis through reorganization of actin cytoskeleton. Rho is activated by extracellular signals such as lysophosphatidic acid (LPA). The actions of Rho are mediated by downstream Rho effectors. One of these effectors is Rho-associated kinase (ROCK) (11, 12) . Two ROCK isoforms have been identified: ROCK-I (also known as ROKβ) and ROCK-II (also known as Rho kinase and ROKα) (13) (14) (15) (16) . ROCK mediates Rho signaling and reorganizes actin cytoskeleton through phosphorylation of several substrates that contribute to the assembly of actin filaments and contractility. Elucidation of the role of ROCK has been facilitated by the introduction of ROCK inhibitors, Y-27632 and fasudil. Studies with these inhibitors have revealed that ROCK regulates various physiological and pathological processes (17) (18) (19) (20) , while they cannot refer to the isoform-specific role of ROCK because ROCK inhibitors inhibit the activity of both ROCK-I and ROCK-II. Furthermore, ROCK inhibitors may potentially inhibit other protein kinases such as protein kinase A (12) .
Several studies have reported that Rho-ROCK pathway is involved in adipogenesis (21, 22) . However, the role of ROCK in adipogenesis still remains to be clarified. We show here the effects of inhibition of ROCK on adipogenesis and examine the molecular mechanisms using pharmacological and genetic approaches. Especially, the adipogenic analysis using MEFs derived from ROCK-I or ROCK-II knockout mice and ROCK-I or ROCK-II siRNA can provide the evidence about the physiological role of ROCK and the isoform-specific role of ROCK in adipogenesis.
EXPERIMENTAL PROCEDURES

Materials
Y-27632 and pioglitazone (AD-4833) were provided by Mitsubishi Pharma (Osaka, Japan) and Takeda Pharmaceutical Company (Osaka, Japan), respectively. Insulin was purchased from Boehringer Mannheim (Mannheim, Germany (23) . Briefly, cells were grown for 2 days post-confluence (referred as day 0) in 10% CS/DMEM. Differentiation was induced with 10% FBS/DMEM containing 0.5 mM IBMX, 0.25 μM DEX and 1 μg/ml insulin for 2 days. The cells were then incubated in 10% FBS/DMEM with insulin for 2 days and maintained hereafter with 10% FBS/DMEM to day 8. Pioglitazone was dissolved in DMSO and added to media within 0.1% of volume. The medium was changed every other day. At day 8, the cells were washed with phosphate-buffered saline (PBS) twice, fixed in 3.7% formaldehyde for 1 h and then stained with 0.6% (w/v) Oil Red O solution (60% isopropanol, 40% water) for 2 h at room temperature. Cells were then washed with water to remove unbound dye. Stained Oil Red O was eluted with isopropanol and quantified by measuring the optical absorbance at 510 nm (24) .
Preparation of primary mouse embryonic fibroblasts and induction of adipogenesis
The generation of ROCK-I and ROCK-II knockout mice was previously reported (25, 26) . ROCK-II knockout mice of a mixed background 129/Sv and C57BL/6N genetic background were backcrossed to the C57BL/6N strain for more than 8 generations. Primary MEFs were harvested from 13.5 d.p.c. embryos of each genotype as previously described (27) . Differentiation of MEFs was induced with 0.5 mM IBMX, 0.25 μM DEX and 10 μg/ml insulin for 6 days and maintained with 10% FBS/DMEM to day 8.
Small interfering RNA (siRNA)
Synthetic siRNAs were purchased from Invitrogen (Carlsbad, CA). siRNAs were delivered into 3T3-L1 cells by a pulse of electroporation with Nucleofector (Amaxa, Gaithersburg, MD). After the electroporation, cells were immediately mixed with the fresh medium for 10 min and reseeded on plates for further examinations. The cells were differentiated 12 h after the electroporation. Negative control siRNA was used as the control of experiments. The targeted nucleotide sequences of the siRNAs were ATTGGTGCTTGTCAGTTAGGCGTGC (ROCK-I) and ATAATTACTCATAAGGTTGACGAGG (ROCK-II).
Preparation of total cell lysates and Western blot analysis
Cells were washed twice with ice-cold PBS and harvested in a lysis buffer (40 mM HEPES, 10 mM EDTA, 100 mM NaF, 10 mM sodium pyrophosphate, 1 mM Na 3 VO 4 , 50 μM okadaic acid, 1% (v/v) Nonidet P-40, 1 mM PMSF and 0.1 mg/ml aprotinin at pH 7.5). For the examination of transcription factors, cells were harvested in a lysis buffer (60 mM Tris-HCl and 1% SDS at pH 6.8). Lysates were heated at 100˚C for 10 min. After centrifugation, supernatants were normalized for protein concentration via the Bradford method and subjected to immunoblotting. For Western blot analysis, proteins were subjected to SDS-PAGE and electroblotted to polyvinylidene fluoride (PVDF) membranes (Polyscreen, NEN Life Science Products, Inc., Boston, MA). Transferred membranes were blocked with Block Ace (Yukijirushi Nyugyo, Sapporo, Japan) and then incubated with the primary antibodies. After washing with PBS, membranes were reacted with secondary antibodies and developed with ECL plus as instructed by the manufacturer. The signal on the blot was detected and quantified with Lumino-Image Analyser LAS-1000 System (Fuji Photo Film Co., Tokyo, Japan).
Immunofluorescence study
The cells were washed once with PBS and fixed as follows. 3T3-L1 cells were fixed first for 1 min with 4% formaldehyde and 0.1% Triton-X in PBS and then for 15 min with 4% formaldehyde alone in PBS. The cells were permeabilized by washing in PBS containing 0.1% Triton-X for 5 min and incubated with PBS containing 3% BSA for 60 min at room temperature. F-actin was stained with Oregon Green phalloidin (Molecular Probes, Carlsbad, CA). Optical sections were obtained with a Carl Zeiss LSM5 Pascal. TaqMan PCR was performed using ABI Prism 7300 Sequence Detection System as instructed by manufacturer (Applied Biosystems, Foster City, CA). Levels of mRNA were normalized to those of 18S mRNA.
Statistical analysis
The data are presented as means ± S.E. Student's t test was used to compare with the control. Differences were accepted as significant at P < 0.05 level.
RESULTS
ROCK expression and actin cytoskeleton during adipogenesis and effect of ROCK inhibitors on adipogenesis
We detected protein expression of ROCK in 3T3-L1 cells by Western blot analysis (Fig. 1A) . In 3T3-L1 preadipocytes (day 0) and mature adipocytes (day 8), both ROCK-I and ROCK-II were expressed. The expression levels of two ROCK isoforms did not significantly change during adipogenesis. Then, we observed actin cytoskeleton by phalloidin staining at preadipocytes and mature adipocytes. During adipogenesis, the structure of filamentous actin was converted from long stress fiber (preadipocyte) to cortical actin (mature adipocyte), suggesting that Rho-ROCK pathway is involved in adipogenesis (Fig. 1B) . To examine the effects of ROCK inhibitors on adipogenesis, 3T3-L1 cells were exposed to 1 μM, 10 μM, 30 μM Y-27632, 10 μM fasudil, 1 μM pioglitazone and 1 μg/ml insulin, respectively in the presence of DEX and IBMX. Y-27632, fasudil or pioglitazone was added to media from day 0 to day 8. Insulin was added to media from the start of differentiation (day 0) to day 4. At day 8, we evaluated the lipid accumulation by Oil Red O staining ( 
Effect of Y-27632 on the expression of adipogenic genes
Because ROCK inhibitors enhanced lipid accumulation, we examined the expression of adipogenic transcription factors C/EBPβ and C/EBPδ at day 2, and C/EBPα and PPARγ at day 4 by Western blot analysis ( Fig. 3 A and B) . In the presence of DEX and IBMX, Y-27632 with a concentration of 30 μM augmented the expression of C/EBPβ (~1.8-fold increase), C/EBPα (~6.5-fold increase) and PPARγ (~5.6-fold increase) while it suppressed that of C/EBPδ (~40% decrease) compared with the non-treated group. One μg/ml insulin did not affect the expression of C/EBPβ and C/EBPδ at day 2 while it enhanced that of C/EBPα and PPARγ at day 4. One μM pioglitazone augmented the expression of C/EBPβ and C/EBPα while it suppressed those of C/EBPδ and PPARγ. The effects of insulin and pioglitazone on the expression of adipogenic trasnscription factors were compatible with previous reports (29, 31) . Furthermore, we examined protein expression of adipogenic genes during the course of differentiation; day 0, day 1, day 2, day 4 and day 8 (Fig. 3C) . Compared with the vehicle-treatment group, 30 μM Y-27632 enhanced the expression of adipogenic transcription factors: C/EBPβ (~1.7-fold increase, day 1), PPARγ (~5.2-fold increase, day 4) and C/EBPα (~11.7-fold increase, day 4) and adipogenic late markers: aP2 (~8.9-fold increase, day 4) and adiponectin (~8.1-fold increase, day 4). Also in this analysis, Y-27632 suppressed the expression of C/EBPδ (~31% decrease, day 2).
Effect of LPA and Y-27632 on actin cytoskeleton and adipogenesis
LPA activates small GTPase Rho via specific G protein-coupled receptors: LPA 1-4 (32) . It has been reported that LPA induces the stress fiber formation in Swiss 3T3 fibroblast, which is inhibited by Y-27632 (33, 34) . Therefore, we examined the regulation of actin cytoskeleton by LPA and Y-27632 in 3T3-L1 preadipocytes (Fig. 4A) . We stimulated serum-starved 3T3-L1 preadipocytes with or without 10 μM LPA after the pretreatment of 30 μM Y-27632 or non-treatment and assessed the effects on actin cytoskeleton by staining cells with phalloidin. LPA addition to serum-starved 3T3-L1 cells spread the cells and induced stress fibers while this change was inhibited by Y-27632. In Y-27632-treated cells without LPA addition, we could not observe stress fibers or thick actin rim in the cell periphery.
We examined the effects of Y-27632 on LPA-treated 3T3-L1 cells by Oil Red O staining. LPA and Y-27632 were added to media from day 0 to day 8. In the presence of DEX, IBMX and insulin, 10 μM Y-27632 enhanced adipogenesis (~20% increase) while 30 μM LPA inhibited it (~32% decrease), consistent with a previous report in 3T3-F442A cells (32) . In 3T3-L1 cells, LPA inhibited adipogenesis in a dose-dependent manner with concentrations of 1 μM, 10 μM and 30 μM. Y-27632 completely restored its inhibition with concentrations of 10 μM and 30 μM (Fig. 4 B  and C) .
Adipogenesis of ROCK-II -/-and ROCK-I -/-MEFs
To establish more directly causal link between ROCK and adipogenesis, primary mouse embryonic fibroblasts (MEFs) prepared from ROCK-II +/+, +/-, -/-and ROCK-I +/+, +/-, -/-mice were subjected to the adipogenic induction culture. Disruption of ROCK-I and ROCK-II protein was confirmed by Western blot analysis ( Fig. 5B and 6B ). ROCK-II protein levels in ROCK-I +/+, +/-and -/-mice did not differ between genotypes. Similarly, ROCK-I protein levels in ROCK-II +/+, +/-and -/-mice did not differ between genotypes. (Fig. 6 A, C and D) .
Effect of knockdown of ROCK on expression of adipogenic transcription factors
To determine whether inhibition of ROCK-II enhances adipogenesis in 3T3-L1 cells, we examined the effect of ROCK-I or ROCK-II knockdown on 3T3-L1 adipogenesis using siRNA technique. We introduced siRNA targeted for ROCK-I or ROCK-II into 3T3-L1 preadipocytes. 3T3-L1 cells were differentiated 12 h after introduction of siRNA. We confirmed the knockdown of ROCK-I or ROCK-II expression by Western blot analysis at day 2. Compared with the negative control group, introduction of ROCK-I and ROCK-II siRNA resulted in ~96% and ~86% decrease, respectively (Fig. 7 A and B) . There is no obvious compensatory increase of the expression of the other ROCK isoform. At day 3, we examined the expression of adipogenic transcription factors by quantitative RT-PCR. ROCK-II siRNA enhanced the expression of PPARγ and C/EBPα compared with the control (~2.1 fold and ~1.8 fold increase, respectively, **P < 0.01) (Fig. 7C) . ROCK-I siRNA did not enhance the expression of PPARγ and C/EBPα significantly (Fig. 7D) .
Effect of inhibition of ROCK on intracellular signaling pathway
We addressed the mechanisms of downstream signaling of Rho-ROCK. It is known that ROCK directly associates with IRS-1 and phosphorylates its serine residues (35-37). We stimulated serum-starved 3T3-L1 preadipocytes with insulin after the pretreatment of Y-27632. Thirty μM Y-27632 inhibited insulin-induced IRS-1 Ser 612 (~35% decrease, **P < 0.01) and IRS-1 Ser 632/635 (~36% decrease, **P < 0.01) phosphorylation and markedly enhanced insulin-induced Akt phosphorylation (~3.6-fold increase, **P < 0.01) compared with non-treated groups ( Fig. 8  A and C) . Regarding MAPK signaling, Y-27632 slightly enhanced p38MAPK phosphorylation (~1.1-fold increase) and inhibited ERK1/2 phosphorylation (~23% decrease) upon the stimulation of insulin (Fig.  8B) . We examined whether an inhibitor of PI3-kinase, wortmannin, blocks the enhancement of 3T3-L1 adipogenesis induced by Y-27632. Wortmannin and Y-27632 were added to media from day 0 to day 8.
Wortmannin with concentrations of 100 nM and 1 μM inhibited the enhancement of preadipocyte differentiation induced by 10 μM Y-27632 in the presence of DEX and IBMX (Fig. 8D) . We examined insulin-induced Akt phosphorylation in ROCK-II knockout MEFs. In ROCK-II -/-and +/-MEFs, insulin-induced Akt phosphorylation was significantly enhanced compared with wild-type MEFs (5 minutes after stimulation; ~6.0-fold increase and ~2.8-fold increase, respectively, **P < 0.01) (Fig. 9A) . In ROCK-I MEFs, there is no significant difference in insulin-induced Akt phosphorylation between each genotype (Fig.  9B) .
DISCUSSION
In the present study, we show that inhibition of ROCK enhances adipogenesis. It is impossible to determine the isoform-specific role of ROCK by treatment of ROCK inhibitors. In addition to pharmacological approaches, we examined the adipogenesis of both ROCK-I -/-MEFs and ROCK-II -/-MEFs. Furthermore, we examined the effects of knockdown of ROCK-I or ROCK-II on 3T3-L1 adipogenesis by RNA interference. To the best of our knowledge, this is the first study demonstrating that inhibition of ROCK-II enhances adipogenesis and insulin-induced Akt phosphorylation. Our results suggest that ROCK-II plays an important role in adipogenesis and insulin signaling.
We examined the ROCK expression in 3T3-L1 cells by Western blot analysis. Both ROCK isoforms are expressed during the course of adipogenesis. A previous study showed that ROCK-II was expressed in 3T3-L1 mature adipocytes (36) while the expression of ROCK-I has not been reported.
Next, we examined the effects of ROCK inhibitors on lipid accumulation in 3T3-L1 cells. We found that two ROCK inhibitors, Y-27632 and fasudil, enhance lipid accumulation, respectively. These findings suggest that inhibition of ROCK enhances adipogenesis. We also assessed when Y-27632 affects adipogenesis. Supplementation with Y-27632 during day 0-4 fully enhances adipogenesis. These results let us speculate that inhibition of ROCK enhances the expression of adipogenic transcription factors. As expected, Y-27632 enhances the expression of adipogenic transcription factors, C/EBPβ, C/EBPα and PPARγ in the presence of DEX and IBMX, which indicates that inhibition of ROCK enhances adipogenesis through the upregulation of adipogenic transcription factors. Following this, Y-27632 enhances the expression of adipogenic late markers, such as aP2 and adiponectin.
We assessed the effects of LPA and Y-27632 on adipogenesis and actin cytoskeleton. Since the Rho-ROCK pathway regulates actin cytoskeleton, we examined the effects of LPA and Y-27632 on actin cytoskeleton with phalliodin staining. We showed that stress fiber formation is augmented by LPA and that it is inhibited by Y-27632 in 3T3-L1 preadipocytes. These results provide the evidence that LPA activates the Rho-ROCK pathway and Y-27632 inhibits the pathway. Then, we showed that LPA inhibits adipogenesis in 3T3-L1 cells consistent with a previous report in 3T3-F442A cells. Furthermore, we showed that Y-27632 restores its inhibition in a dose-dependent manner. These results indicate that the Rho-ROCK pathway plays an important role in adipogenesis.
To determine the isoform-specific role of ROCK and to entirely exclude the non-specific effects of ROCK inhibitors, we examined adipogenesis of ROCK-I -/-and ROCK-II -/-MEFs. We demonstrated that targeted disruption of ROCK-II enhances adipogenesis and that, in contrast, that of ROCK-I does not enhance adipogenesis. Furthermore, Y-27632 enhances lipid accumulation in ROCK-I -/-MEFs and does not enhance lipid accumulation in ROCK-II -/-MEFs. It suggests that inhibition of endogenous ROCK-II enhances adipogenesis. In 3T3-L1 cells, we examined the effect of knockdown of ROCK-I or ROCK-II on adipogenesis using siRNA. We showed that ROCK-II siRNA enhances the expression of adipogenic transcription factors while ROCK-I siRNA does not enhance it. Taken together, our results from the pharmacological and genetic approaches indicate that inhibition of ROCK, especially ROCK-II, enhances adipogenesis.
We investigated the mechanisms of the enhancement of adipogenesis by inhibition of ROCK. We demonstrated that Y-27632 inhibits IRS-1 serine phosphorylation and markedly enhances Akt phosphorylation upon the stimulation of insulin in 3T3-L1 preadipocytes. Previously, it has been reported that insulin/IGF-1 signaling is required for adipogenesis. MEFs derived from IRS-1 -/-mice do not have enough differentiation properties (27) . IRS-1 and IRS-3 double knockout mice exhibit lipodystrophy (38) . Constitutively active Akt causes spontaneous differentiation in 3T3-L1 cells (39) . Furthermore, we also demonstrated that an inhibitor of PI3-kinase, wortmannin, blocks the enhancement of adipogenesis induced by Y-27632. Therefore, augmentation of insulin signaling may contribute to the enhancement of preadipocyte differentiation. Concerning MAPK signaling, we showed that Y-27632 slightly enhances p38MAPK phosphorylation and slightly inhibits ERK1/2 phosphorylation in this cell line. Regarding ERK1/2 and p38MAPK, a great deal of evidence about the molecular link between MAPK and adipogenesis has been accumulating (40) (41) (42) (43) (44) (45) . However, their roles in adipogenesis are still controversial. In addition to pharmacological approaches, we showed that in ROCK-II -/-MEFs and even in ROCK-II +/-MEFs, insulin-induced Akt phosphorylation is enhanced compared with that in wild-type MEFs while in ROCK-I MEFs, there is no significant difference in insulin-induced Akt phosphorylation between each genotype. It provides the direct evidence that loss of ROCK-II enhances insulin-induced Akt phosphorylation.
Adipogenic analysis of both ROCK-I -/-and ROCK-II -/-MEFs revealed that loss of ROCK-II, not ROCK-I, enhances adipogenesis. The isoform-specific role of ROCK has been still obscure both in vitro and in vivo. As previously reported, loss of ROCK-I results in the eyelid open at birth (EOB) and omphalocele, while loss of ROCK-II results in placental dysfunction, intrauterine growth retardation and fetal death. However, recently it has been reported that ROCK-II knockout mice backcrossed in the C57BL6/N background exhibit not only the placental phenotype but also EOB and omphalocele (47) . Concerning actin cytoskeletal regulation, it suggests that ROCK-I and ROCK-II cooperatively regulate actin bundle assembly required for eyelid and ventral body wall closure. In this context, our findings that inhibition of ROCK-II, not ROCK-I, enhances adipogenesis is a novel isoform-specific role of ROCK.
Regarding the ROCK and insulin signaling, we showed that a ROCK inhibitor reduces IRS-1 serine phosphorylation and increases Akt phosphorylation in 3T3-L1 preadipocytes. It is known that ROCK directly associates with IRS-1 and phosphorylates its serine residues (35) (36) (37) . In addition, previous studies have reported that IRS-1 serine phosphorylation negatively regulates insulin signaling in vascular smooth muscle cells (37) and NIH3T3 fibroblasts (46) . However, recently, it has been reported that ROCK phosphorylates IRS-1 serine residues and positively regulates insulin signaling in 3T3-L1 mature adipocytes (36) . The discrepancy between these reports shows that IRS-1 serine phosphorylation regulates insulin signaling differently depending on cell types. Therefore, there could be a difference in the regulation of insulin signaling by IRS-1 serine phosphorylation between preadipocytes and mature adipocytes.
In summary, the present study first provides the robust and direct evidence that inhibition of ROCK-II enhances adipogenesis accompanied by the upregulation of adipogenic transcription factors and that inhibition of ROCK-II enhances insulin-induced Akt phosphorylation. These results indicate that inhibition of ROCK-II enhances adipogenesis, at least in part, via augmentation of insulin signaling. Finally, these findings raise the possibility that ROCK-II is a novel target for the treatment of obesity, insulin resistance and type 2 diabetes. (B) Equal amounts of proteins harvested at day 2 were subjected to Western blot analysis using antibodies against C/EBPβ, C/EBPδ and β-actin. (C) Equal amounts of proteins harvested at day 0, 1, 2, 4 and 8 were subjected to Western blot analysis using antibodies against PPARγ, C/EBPα, C/EBPβ, C/EBPδ, aP2, adiponectin and β-actin. β-actin proteins were monitored as hallmarks during adipocyte differentiation. Pio: pioglitazone.
All data are representatives of at least three independent experiments. 
